Epigenomics AG (FRA:ECX)

Epigenomics AG Revenue

In the year 2025, Epigenomics AG had annual revenue of 24.00K EUR. Epigenomics AG had revenue of 20.00K in the half year ending December 31, 2025, a decrease of -85.32%.

• Revenue: 24.00K
• Revenue Growth: n/a
• P/S Ratio: 34.35
• Revenue / Employee: 8.00K
• Employees: 3
• Market Cap: 824.36K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	24.00K	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	339.00K	-560.00K	-62.29%
Dec 31, 2022	899.00K	-5.30M	-85.51%
Dec 31, 2021	6.20M	5.36M	636.70%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 17, 2026

Data Sources Report a data error